Table 1.

Crohn’s Disease patients on teduglutide

Gender	Age	Disease Duration (years)	Disease Location	Disease Phenotype	# of bowel resections	Ostomy	Medications
Female	46	25	Ileo-colonic	Penetrating	3	Ileostomy	Certolizumab, budesonide, prednisone
Female	37	14	Ileo-colonic	Penetrating	2	Ileostomy	Methotrexate, budesonide, Ustekinumab
Male	56	38	Ileo-colonic	Penetrating	3	None	None
Female	38	17	Ileo-colonic	Penetrating	6	Ileostomy	Adalimumab
Female	41	23	Ileo-colonic	Penetrating	3	Ileostomy	None
Male	45	26	Ileo-colonic	Penetrating	4	Colostomy	Infliximab, thiopurine
Female	60	19	Ileal	Stricturing	3	None	Narcotics
Female	68	46	Ileo-colonic	Stricturing	8	Ileostomy	Mesalamine, narcotics
Male	59	45	Ileo-colonic	Stricturing	6	Ileostomy	None
Female	59	35	Ileal	Stricturing	5	None	Thiopurine, prednisone
Female	49	19	Ileo-colonic	Stricturing	1	None	Ustekinumab, narcotics
Female	72	48	Ileo-colonic	Stricturing	4	Ileostomy	Thiopurine
Male	51	31	Ileo-colonic	Stricturing	5	None	Vedolizumab, thiopurine